Literature DB >> 20798947

[Minimally invasive angle surgery. The Trabectome].

J F Jordan1, M Neuburger, T Reinhard.   

Abstract

The Trabectome provides a new perspective in angle surgery for open angle glaucoma. Through a 1.7 mm clear cornea tunnel, the juxtacanalicular meshwork is electroablated under gonioscopic control. Thereby, the collector channels in the outer wall of Schlemm's canal are uncovered and resistance to trabecular outflow is removed. From the literature and from our own experience, a pressure reduction by 30-35% can be achieved with a simultaneous reduction of eye drops by 50%. The Trabectome can conveniently be combined with phako-emulsification. Serious complications have not yet been reported. As the conjunctiva remains completely untouched, trabeculectomy, if necessary, could be performed without prognostic restrictions. With a realistic target pressure of approximately 16 mmHg, Trabectome surgery is indicated in patients with moderate optic nerve damage.

Entities:  

Mesh:

Year:  2010        PMID: 20798947     DOI: 10.1007/s00347-010-2235-3

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  16 in total

1.  Clinical results with the Trabectome, a novel surgical device for treatment of open-angle glaucoma.

Authors:  Don Minckler; George Baerveldt; Marina Alfaro Ramirez; Sameh Mosaed; Richard Wilson; Tarek Shaarawy; Barend Zack; Laurie Dustin; Brian Francis
Journal:  Trans Am Ophthalmol Soc       Date:  2006

2.  Trabectome (trabeculectomy-internal approach): additional experience and extended follow-up.

Authors:  Don Minckler; Sameh Mosaed; Laurie Dustin; Brian Francis Ms
Journal:  Trans Am Ophthalmol Soc       Date:  2008

3.  Combined cataract extraction and trabeculotomy by the internal approach for coexisting cataract and open-angle glaucoma: initial results.

Authors:  Brian A Francis; Don Minckler; Laurie Dustin; Shahem Kawji; Jason Yeh; Arthur Sit; Sameh Mosaed; Murray Johnstone
Journal:  J Cataract Refract Surg       Date:  2008-07       Impact factor: 3.351

4.  Effects of Er:YAG laser trabecular ablation on outflow facility in cadaver porcine eyes.

Authors:  P C Jacobi; T S Dietlein; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

5.  Clinical results with the Trabectome for treatment of open-angle glaucoma.

Authors:  Don S Minckler; George Baerveldt; Marina Ramirez Alfaro; Brian A Francis
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

6.  [Risks of 360 degree suture trabeculotomy].

Authors:  B R Gloor
Journal:  Ophthalmologe       Date:  1998-02       Impact factor: 1.059

Review 7.  [Trabecular meshwork bypass surgery for glaucoma].

Authors:  T S Dietlein; A Schild; A Rosentreter; J F Jordan; G K Krieglstein
Journal:  Ophthalmologe       Date:  2009-02       Impact factor: 1.059

8.  Clinical evaluation of the aqueous outflow system in primary open-angle glaucoma for canaloplasty.

Authors:  Matthias C Grieshaber; Ané Pienaar; Jan Olivier; Robert Stegmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

9.  Circumferential viscodilation and tensioning of Schlemm canal (canaloplasty) with temporal clear corneal phacoemulsification cataract surgery for open-angle glaucoma and visually significant cataract: one-year results.

Authors:  Bradford Shingleton; Manfred Tetz; Norbert Korber
Journal:  J Cataract Refract Surg       Date:  2008-03       Impact factor: 3.351

10.  A prospective trial of phaco-trabeculotomy combined with deep sclerectomy versus phaco-trabeculectomy.

Authors:  Christoph Lüke; Thomas S Dietlein; Matthias Lüke; Walter Konen; Günter K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-15       Impact factor: 3.117

View more
  1 in total

1.  Success of combined cataract extraction plus excimer laser trabeculotomy exceeds that of combined ab interno trabeculectomy with the trabectome or cataract extraction alone.

Authors:  Lidija Jozic; Joachim Magner; Jens Funk; Marc Töteberg-Harms
Journal:  Int Ophthalmol       Date:  2019-11-14       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.